abstract |
The present invention provides a phosphorus-containing compound, which is a compound having the following structure. The compound has excellent hydrophilicity as a novel immune cell migration inhibitor and can be developed as an ophthalmic solution. In addition, by having a very strong inhibitory ability against immune cell migration, it can alleviate the symptoms of most dry eye patients. |